Faidon Magkos

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study
    Faidon Magkos
    Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Metabolism 60:1045-9. 2011
  2. doi Exercise and fat accumulation in the human liver
    Faidon Magkos
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Curr Opin Lipidol 21:507-17. 2010
  3. pmc Leptin in human physiology and pathophysiology
    Christos S Mantzoros
    Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Am J Physiol Endocrinol Metab 301:E567-84. 2011
  4. pmc Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals
    Hyun Seuk Moon
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Endocr Rev 34:377-412. 2013
  5. doi Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women
    Elizabeth Sienkiewicz
    Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Metabolism 60:1211-21. 2011
  6. pmc Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized,
    Konstantinos N Aronis
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Metabolism 61:577-82. 2012
  7. pmc Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet
    Greeshma K Shetty
    Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School and Harvard School of Public Health, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
    Eur J Endocrinol 165:249-54. 2011
  8. pmc Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans
    Eun Seok Kang
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, SL Room 412, Boston, Massachusetts 02215, USA
    Eur J Endocrinol 164:911-7. 2011
  9. pmc Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis
    Jutta M Nagel
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Nutrition 28:67-75. 2012
  10. pmc Brain responses to food images during the early and late follicular phase of the menstrual cycle in healthy young women: relation to fasting and feeding
    Miguel Alonso-Alonso
    Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School, Boston, MA 02215, USA
    Am J Clin Nutr 94:377-84. 2011

Collaborators

  • Maria Dalamaga
  • Giuseppe Matarese
  • Li Su
  • Ole Petter R Hamnvik
  • Mary Yannakoulia
  • Eun Seok Kang
  • Rihong Zhai
  • Jutta M Nagel
  • Christos S Mantzoros
  • Mary Brinkoetter
  • Hyun Seuk Moon
  • Konstantinos N Aronis
  • Elizabeth Sienkiewicz
  • Sang Yong Kim
  • Aoife M Brennan
  • John P Chamberland
  • Miguel Alonso-Alonso
  • Greeshma K Shetty
  • Anastasia Koniaris
  • Jason Paruthi
  • Stergios A Polyzos
  • Laura L Sweeney
  • Maria T Vamvini
  • Fernando A Barrios
  • Alvaro Pascual-Leone
  • Rafael Rojas
  • Despina Sykoutri
  • Anne Rifkin-Graboi
  • Geetha Mylvaganam
  • Alex M Depaoli
  • Kalliopi M Arampatzi
  • Sharon Chou
  • Tina A Dardeno
  • Ingrid Boyd
  • Maria Vamvini
  • Chuanyun Gao
  • Xiaowen Liu
  • Florencia Ziemke

Detail Information

Publications12

  1. pmc Leptin replacement improves postprandial glycemia and insulin sensitivity in human immunodeficiency virus-infected lipoatrophic men treated with pioglitazone: a pilot study
    Faidon Magkos
    Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Metabolism 60:1045-9. 2011
    ..Results from this pilot study should be confirmed in larger clinical trials...
  2. doi Exercise and fat accumulation in the human liver
    Faidon Magkos
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Curr Opin Lipidol 21:507-17. 2010
    ..Regular exercise improves many cardiometabolic risks factors; however, its effect on intrahepatic triglyceride (IHTG) content remains elusive. This article summarizes available data regarding the effects of exercise on IHTG...
  3. pmc Leptin in human physiology and pathophysiology
    Christos S Mantzoros
    Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Am J Physiol Endocrinol Metab 301:E567-84. 2011
    ..Results from ongoing studies are expected to further increase our understanding of the role of leptin and the potential clinical applications of leptin or its analogs in human therapeutics...
  4. pmc Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals
    Hyun Seuk Moon
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Endocr Rev 34:377-412. 2013
    ....
  5. doi Long-term metreleptin treatment increases bone mineral density and content at the lumbar spine of lean hypoleptinemic women
    Elizabeth Sienkiewicz
    Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Metabolism 60:1211-21. 2011
    ..Results from this pilot study should be confirmed by future, larger clinical trials and need to be extended by studying bone microarchitecture and fracture risk...
  6. pmc Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized,
    Konstantinos N Aronis
    Division of Endocrinology, Diabetes and Metabolism, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Metabolism 61:577-82. 2012
    ..Four days of walnut consumption (48 g/d) leads to mild increases in apolipoprotein A concentrations, changes that may precede and lead to the beneficial effects of walnuts on lipid profile in obese subjects with the metabolic syndrome...
  7. pmc Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet
    Greeshma K Shetty
    Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School and Harvard School of Public Health, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, Massachusetts 02215, USA
    Eur J Endocrinol 165:249-54. 2011
    ..Whether the reduction in leptin concentration during long-term weight loss in obese individuals is linked to the same neuroendocrine changes seen in lean, leptin-sensitive subjects remains to be fully clarified...
  8. pmc Circulating vaspin and visfatin are not affected by acute or chronic energy deficiency or leptin administration in humans
    Eun Seok Kang
    Division of Endocrinology, Diabetes, and Metabolism, Department of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, SL Room 412, Boston, Massachusetts 02215, USA
    Eur J Endocrinol 164:911-7. 2011
    ..We thus examined whether vaspin and visfatin are affected by short- and long-term energy deprivation and leptin administration in human subjects in vivo...
  9. pmc Dietary walnuts inhibit colorectal cancer growth in mice by suppressing angiogenesis
    Jutta M Nagel
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA
    Nutrition 28:67-75. 2012
    ..The aim of the present study was to examine the effect of dietary walnuts on colorectal cancer in vivo and to comparatively evaluate their efficacy in relation to flaxseed oil...
  10. pmc Brain responses to food images during the early and late follicular phase of the menstrual cycle in healthy young women: relation to fasting and feeding
    Miguel Alonso-Alonso
    Division of Endocrinology, Diabetes and Metabolism, Harvard Medical School, Boston, MA 02215, USA
    Am J Clin Nutr 94:377-84. 2011
    ..Ovarian steroids can influence brain areas that process food-related information, but the specific contribution of individual hormones and the importance of the prandial state remain unknown...
  11. pmc Variants of the adiponectin and adiponectin receptor-1 genes and posttransplantation diabetes mellitus in renal allograft recipients
    Eun Seok Kang
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, 330, Brookline Avenue, ST 816, Boston, Massachusetts 02215, USA
    J Clin Endocrinol Metab 97:E129-35. 2012
    ..Adiponectin (ADIPOQ) and adiponectin receptor-1 (ADIPOR1) gene polymorphisms have been associated with type 2 diabetes. However, it is unknown whether these polymorphisms are also risk factors for PTDM...
  12. pmc Leptin treatment reduces body fat but does not affect lean body mass or the myostatin-follistatin-activin axis in lean hypoleptinemic women
    Mary Brinkoetter
    Division of Endocrinology, Diabetes, and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA
    Am J Physiol Endocrinol Metab 301:E99-E104. 2011
    ..20) whether in the 10-wk trial or the 9-mo trial. We conclude that metreleptin administration in lean hypoleptinemic women reduces fat mass exclusively and does not affect lean body mass or the myostatin-follistatin-activin axis...